Henning Schwanhaeusser

T-CURX is a Biotech company, spun-out from the University Clinics Würzburg, Germany, developing first- and best-in-class personalized immunotherapies on the basis of CAR-T cells. CAR-T cells are a transformative, one-shot, chemotherapy-free targeted and personalized cancer treatment. T-CURX has exclusive licenses for proprietary technologies and CAR-T product opportunities developed in the laboratory of Prof. M. Hudecek, Würzburg, Germany one of the leading European clinical CAR-T cell laboratories. T-CURX leverages several cutting-edge CAR-T engineering technologies, including virus-free transposon based genetic engineering and a highly flexible and modular CAR format. This provides unparalleled flexibility, efficacy, safety, but also scalability for developing CAR-T cells at significantly lower costs than conventional lentivirus-based CAR-T cell manufacturing.

We are building the next gen marketplace for Gen Z, enabling community-building and direct interaction via livestream shopping. Join VIOU and be part of a platform that will revolutionise e-commerce!

Robotic solutions for sustainable farming. About the Robot --- Our robot is designed for mechanical weed removal, optimized for sugar beets and salads. It processes 3 rows in parallel and uses a 99% accurate AI-based optical system for weed/crop detection. With its lightweight aluminum body, operation on drying ground is possible way earlier than with heavy machines.

At NBE Therapeutics we strive to develop best-in-class oncology treatments to increase survival and improve quality of life for cancer patients worldwide. Through our highly innovative novel in-house developed technologies, we have created a next generation antibody drug conjugate platform targeting solid tumors. Our platform allows us to develop targeted medicines, that through a long-lasting immune oncology effect, could reduce or even eradicate tumors. Our dedicated international team has been able to create a pipeline of ADC product candidates in various stages of development to enter clinical phases to create better treatments for cancer patients in need of more selective drugs.

We support companies in complex digital transformation processes, combining experience and method with deep technological knowledge, which is the result of continuous research and development. The whole process is based on the Lean principles. We develop software following Agile methodologies inspired by the Agile Manifesto and optimized with DevOps and Continuous Delivery practices to turn ideas into successful digital products. We are more than just passionate developers. We are Cloud and DevOps engineers, Strategist and Designer. Our workflow is transparent and documented in our PlayBook, we have put our values down on paper so that you can read them in our Manifesto. Our mission is to create the most inspiring place where talented people can deliver cutting edge technology, leading the customer transition to a cloud-native era. Want to join us? https://www.sparkfabrik.com/en/careers/

T-CURX is a Biotech company, spun-out from the University Clinics Würzburg, Germany, developing first- and best-in-class personalized immunotherapies on the basis of CAR-T cells. CAR-T cells are a transformative, one-shot, chemotherapy-free targeted and personalized cancer treatment. T-CURX has exclusive licenses for proprietary technologies and CAR-T product opportunities developed in the laboratory of Prof. M. Hudecek, Würzburg, Germany one of the leading European clinical CAR-T cell laboratories. T-CURX leverages several cutting-edge CAR-T engineering technologies, including virus-free transposon based genetic engineering and a highly flexible and modular CAR format. This provides unparalleled flexibility, efficacy, safety, but also scalability for developing CAR-T cells at significantly lower costs than conventional lentivirus-based CAR-T cell manufacturing.

We are building the next gen marketplace for Gen Z, enabling community-building and direct interaction via livestream shopping. Join VIOU and be part of a platform that will revolutionise e-commerce!

Robotic solutions for sustainable farming. About the Robot --- Our robot is designed for mechanical weed removal, optimized for sugar beets and salads. It processes 3 rows in parallel and uses a 99% accurate AI-based optical system for weed/crop detection. With its lightweight aluminum body, operation on drying ground is possible way earlier than with heavy machines.

At NBE Therapeutics we strive to develop best-in-class oncology treatments to increase survival and improve quality of life for cancer patients worldwide. Through our highly innovative novel in-house developed technologies, we have created a next generation antibody drug conjugate platform targeting solid tumors. Our platform allows us to develop targeted medicines, that through a long-lasting immune oncology effect, could reduce or even eradicate tumors. Our dedicated international team has been able to create a pipeline of ADC product candidates in various stages of development to enter clinical phases to create better treatments for cancer patients in need of more selective drugs.